inVentiv completes i3 acquisition
Acquisition hungry CRO inVentiv Health has completed the purchase of i3, positioning it for the next stage of its reorganisation plan.
Acquisition hungry CRO inVentiv Health has completed the purchase of i3, positioning it for the next stage of its reorganisation plan.
GlaxoSmithKline (GSK) has announced plans to buy its joint venture Shenzhen GSK Neptunus Biologicals (GSKNB) to expand influenza vaccine production capacity in China.
Sartorius Stedim Biotech (SSB) has teamed up with packaging firm Sudpack Medica AG in a deal focused on making plastic films for biopharmaceutical industry applications.
Quotient Amersham Radiochemicals has been rebranded as Quotient Custom Radiolabelling in the latest stage of two year expansion programme by parent Quotient Bioresearch.
US stem-cell therapy firm NeoStem predicts that output of its China-based generic antibiotics subsidiary Suzhou Erye Pharmaceutical will increase after further manufacturing approval from the SFDA.